PRISM BioLab Co.,LTD

206A・Growth Market・Pharmaceuticals

Official website

PRISM BioLab Co.,LTD

206A・Growth Market・Pharmaceuticals

Official website

PRISM BioLab Co.,LTD206A

Reference Indicators

Market Cap

55¥100M

P/E (Forecast)

—

P/B

2.0x

Dividend Yield (Forecast)

0.00%

ROE

-30.9%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2024Sep 2024	2025Sep 2025
Net Sales	305	677
Cost of Sales	145	407
Gross Profit	160	269
SG&A Expenses	942	1,044
Operating Income	-782	-774
Non-operating Income	0	26
Non-operating Expenses	49	0
Ordinary Income	-831	-748
Extraordinary Income	0	—
Extraordinary Losses	216	82
Pre-tax Income	-1,048	-831
Income Taxes	1	2
Net Income	-1,049	-833
Gross Margin	52.5%	39.8%
Operating Margin	-256.0%	-114.3%
ROA	-23.2%	-27.0%
ROE	-30.0%	-30.9%